Add to ORKGWe studied a nucleoside reverse transcriptase inhibitor (NRTI)-sparing regimen for the treatment of children infected with NRTI-resistant HIV-1. The combination of lopinavir/ritonavir and efavirenz suppressed HIV-1 levels for a prolonged period and resulted in a significant increase in CD4+ T cell numbers despite an extensive prior treatment with NRTI (>4 years). Observed side effects were transient with the exception of dyslipidaemia
Context Although protease inhibitors are used routinely in adults with human immunodeficiency virus ...
Context Although protease inhibitors are used routinely in adults with human immunodeficiency virus ...
Context Although protease inhibitors are used routinely in adults with human immunodeficiency virus ...
Contains fulltext : 59321.pdf (publisher's version ) (Closed access)We studied a n...
Contains fulltext : 59320.pdf (publisher's version ) (Closed access
Introduction Treatment options for children with HIV-1 are limited. We aimed to compare activity an...
We here present the study results of 21 HIV-1 infected children who were treated with indinavir plus...
AIM: To evaluate the long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/rito...
Selection of the most effective and safest high-active antiretroviral therapies is a critical issue ...
AIM: To evaluate the long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/rito...
AIM: To evaluate the long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/rito...
Importance Worldwide, the nonnucleoside reverse transcriptase inhibitors (NNRTIs) efavirenz and nevi...
ABSTRACTThe efficacy and safety of a combination regimen including either efavirenz or lopinavir–rit...
Selection of the most effective and safest high-active antiretroviral therapies is a critical issue ...
INTRODUCTION: Treatment options for children with HIV-1 are limited. We aimed to compare activity an...
Context Although protease inhibitors are used routinely in adults with human immunodeficiency virus ...
Context Although protease inhibitors are used routinely in adults with human immunodeficiency virus ...
Context Although protease inhibitors are used routinely in adults with human immunodeficiency virus ...
Contains fulltext : 59321.pdf (publisher's version ) (Closed access)We studied a n...
Contains fulltext : 59320.pdf (publisher's version ) (Closed access
Introduction Treatment options for children with HIV-1 are limited. We aimed to compare activity an...
We here present the study results of 21 HIV-1 infected children who were treated with indinavir plus...
AIM: To evaluate the long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/rito...
Selection of the most effective and safest high-active antiretroviral therapies is a critical issue ...
AIM: To evaluate the long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/rito...
AIM: To evaluate the long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/rito...
Importance Worldwide, the nonnucleoside reverse transcriptase inhibitors (NNRTIs) efavirenz and nevi...
ABSTRACTThe efficacy and safety of a combination regimen including either efavirenz or lopinavir–rit...
Selection of the most effective and safest high-active antiretroviral therapies is a critical issue ...
INTRODUCTION: Treatment options for children with HIV-1 are limited. We aimed to compare activity an...
Context Although protease inhibitors are used routinely in adults with human immunodeficiency virus ...
Context Although protease inhibitors are used routinely in adults with human immunodeficiency virus ...
Context Although protease inhibitors are used routinely in adults with human immunodeficiency virus ...